FDA mesh actions: which device and which repair?

FDA stopped sales of mesh for vaginal POP repair in April 2019. Slings and repairs through the abdomen differ. The action does not order all implants removed.

What did FDA order in April 2019?

FDA stopped sales of mesh for vaginal POP repair. Two makers had three products left on sale. The action did not cover every surgical mesh.

Pelvic organ prolapse, called POP, means organs drop as their support weakens. The remaining products were Boston Scientific’s Uphold LITE and Xenform and Coloplast’s Restorelle DirectFix Anterior. FDA rejected their approval applications because the submitted evidence did not reasonably assure safety and effectiveness. This scope matters before linking an old operation to the action.

What happened in the later POP study reviews?

FDA reviewed follow-up after those products left the market. Outcomes at 36 months were similar to tissue-only repair. FDA still found added exposure and erosion concerns.

The Boston Scientific review entry is dated August 16, 2021; the Coloplast entry is October 17, 2022. FDA kept its unfavorable benefit-risk view for this use. Similar outcomes at one follow-up period do not erase the agency’s concern or establish any patient’s cause.

Did the same action cover urinary slings?

No. FDA reviews slings for urine leaks on their own. Its 2024 review compared mini-slings with longer slings.

The agency examined manufacturer studies through 36 months and thirty randomized trials with follow-up through five years. It found comparable clinical performance, rather than no risk. Those studies were not a review of vaginal POP mesh or a guarantee for every brand and patient.

Does an FDA warning mean I should have removal?

Ask your clinician about your own findings. FDA advises routine follow-up if you are well and satisfied. New symptoms should be discussed with the care team.

Patient guidance identifies persistent bleeding or discharge, pelvic or groin pain and pain during sex. Tell a provider you have mesh before another procedure. Neither the stop-sale action nor a website can choose a removal plan for you.

Can adverse-event reports prove how often harm occurs?

Reports can flag possible safety problems. They can be incomplete or late. They do not tell how often harm occurs without a count of implants.

FDA describes underreporting, missing denominators and inaccurate or incomplete information as limitations of its passive report system. A reported problem is not a finding that a product caused one person’s harm. Ask for a study’s design and population before applying a risk number to yourself.

Which records help match the warning to my operation?

Check the product and what it treated. Ask whether the route was vaginal or abdominal. Keep a separate note for any urinary sling.

Request the surgery record and available labeling from the provider. If two procedures were done together, identify each one rather than guessing from the word mesh. Ask a lawyer how the correct regulatory record relates to the claimed injury; a warning alone does not decide liability.